- Home
- CVAC
CVAC
CureVac N.V.
as 11-15-2024 4:00pm EST
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
| Founded: | 2000 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 637.1M | IPO Year: | 2020 |
| Target Price: | $10.00 | AVG Volume (30 days): | 540.3K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.21 - $6.30 | Next Earning Date: | 11-12-2024 |
| Revenue: | $70,565,734 | Revenue Growth: | 75.11% |
| Revenue Growth (this year): | 123.97% | Revenue Growth (next year): | -50.06% |
Latest CureVac N.V. News
CVAC Breaking Stock News: Dive into CVAC Ticker-Specific Updates for Smart Investing
Pharma Voice
2 days ago
Where are they now? 4 biotechs that soared then crashed during the pandemic
GuruFocus.com
4 days ago
CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...
ACCESSWIRE
5 days ago
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
ACCESSWIRE
10 days ago
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
MT Newswires
13 days ago
CureVac Appoints Axel Sven Malkomes as CFO
ACCESSWIRE
13 days ago
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer
ACCESSWIRE
13 days ago
CureVac to Present at the 12th International mRNA Health Conference
Simply Wall St.
18 days ago
US Penny Stocks To Watch In October 2024
Compare CVAC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CVAC CureVac N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.